Clinical Trial Update: Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase IIA open-label study to evaluate BL-8040 followed by immunosuppressive therapy in adults with aplastic anemia or hypoplastic myelodysplastic syndrome; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Hypoplastic Myelodysplastic Syndrome

Drugs mentioned

• BL-8040

Snippet

Sponsor: BioLineRx, Ltd. | Conditions: Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED